Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation for Enhancing Botulinum Toxin A in Hyperactive Masseter Muscle
NCT07270042Not yet recruiting
- Sponsor
- Tishreen University
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of zinc gluconate in masseter muscle hypertrophy (MMH) (2 arms), sponsored by Tishreen University. Primary endpoint: Percentage change in masseter electromyographic (EMG) amplitude at 12 weeks. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
zinc gluconate
03
Conditions
masseter muscle hypertrophy (MMH)
Beyond the preview
Go deeper on NCT07270042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07270042.